Does the lower nitric oxide level cause cardiovascular changes in major depressed women?

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 5, 2008, Pages 309-313

  Arslan, Ayse ^a   Uzun, Metehan ^b  

^a Kars State Hospital   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

Author keywords

Blood pressure; Major depression; Nitric oxide; QTc; Women

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; AUSCULTATION; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MAJOR DEPRESSION; NITRATE BLOOD LEVEL; NITRIC OXIDE BLOOD LEVEL; NITRITE BLOOD LEVEL; QT INTERVAL; QT PROLONGATION; SPECTROMETRY; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER, MAJOR; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; NITRIC OXIDE;

EID: 56849112219     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BLAZER DG, KESSLER RC, MC GONAGLE KA, SWARTZ MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry 1994; 151: 979-986.
2. HOLSBOER F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23: 477-501.
3. LE MELLEDO JM, MAHIL N, BAKER B, GLEN DS. Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder? J Psychiatry Neurosci 2004; 29: 414-416.
4. CHRAPKO WE, JURASZ P, RADOMSKI MW, LARA N, ARCHER SL, LE MELLEDO JM. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry 2004; 56: 129-134.
5. LECLERCO B, JAIMES EA, RAU L. Nitric oxide synthase and hypertension. Curr Opin Nephrol Hypertens 2002; 11: 185-189.
6. TOIVONEN L. More light on QT interval measurement. Heart 2002; 87: 193-194.
7. RUDISH B, NEMEROFF CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003; 54: 227-240.
8. CARNEY RM, FREEDLAND KE, MILLER GE, JAEFE AS. Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanisms. J Psychosom Res 2002; 53: 897-902.
9. MIRANDA KM, ESPEY MG, WINK DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71.
10. BAZETT JC. An analysis of time relation of electrocardiogram. Heart 1920; 7: 353-367.
11. SELLEY ML. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. J Affect Disorders 2004; 80: 249-256.
12. CLAES SJ. Corticotrophin-releasing hormone (CRH) in psychiatry: From stress to psychopathology. Ann Med 2004; 36: 50-61.
13. CATALAN R, GALLART JM, CASTELLANOS JM, GALARD R. Plasma corticotrophin-releasing factor in depressive disorders. Biol Psychiatry 1998; 44: 15-20.
14. JOYNT KE, WHELLAN DJ, O'CONNOR CM. Depression and cardiovascular disease: Mechanisms of interaction. Biol Psychiatry 2003; 54: 248-261.
15. ANDERSON TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 2003; 8: 71-86.
16. WALLERATH T, WITTE K, SCHAFER SC, SCHWARZ PM, PRELLWITZ W, WOHLFART P, KLEINERT H, LEHR HA, LEMMER B, FORSTERMANN U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 1999; 96: 13357-13362.
17. ROGERS KM, BONAR CA, ESTRELIA JL, YANG S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol 2002; 283: H1922-H1928.
18. VALLANCE P, LEONE A, CALVER A, COLLIER J, MONCADA S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.
19. BÖGER RH, BODE-BÖGER SM, TSAO PS, LIN PS, CHAN JR, COOKE JP. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 2000; 36: 2287-2295.
20. GRAEFF FG, GUIMARAES FS, DE ANDRADE TG, DEAKIN JF. Role of 5-HT stress, anxiety and depression. Pharmacol Biochem Behav 1996; 54: 129-141.
21. COSTA MA, MARCHETTI M, BALASZCZUK AM, ARRANZ CT. Effects of L-arginine and furosemide on blood pressure and renal function in volume-expanded rats. Clin Exp Pharmacol Physiol 2001; 28: 528-532.
22. OKIN PM, DEVEREUX RB, HOWARD BW, FABSITZ RR, LEE ET, WELTY TK. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The strong heart study. Circulation 2000; 101: 61-66.
23. NAHSHONI E, AIZENBERG D, STRASBERG B, DORFMAN P, SIGLER M, IMBAR S, WEIZMAN A. QT dispersion in the surface electrocardiogram in elderly patients with major depression. J Affect Disorders 2000; 60: 197-200.
24. ISHIDA S, NAKAGAWA M, FUJINO T, YONEMOCHI H, SAIKAWA T, IXO M. Circadian variation of QT interval dispersion: Correlation with heart rate variability. J Electrocardiol 1997; 30: 205-210.
25. SCHWARTZ JP, LA ROVERE MT, VANOLI E. Autonomic nervous system and sudden cardiac death. Experimental basic and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85: 177-191.
26. GLASSMAN AH, SHAPIRO PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155: 4-11.
27. CARNEY RM, FREEDLAND KE, SHELINE YI, WEISS ES. Depression and coronary heart disease: A review for cardiologists. Clin Cardiol 1997; 20: 196-200.
28. GLASSMAN AH, BIGGER JT. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158: 1774-1782.